Expert Radar
Dr. Mingyi Chen, MD, PhD
UCLA Santa Monica Medical Center (Los Angeles, CA)
Doctor of Medicine
Dr. Mingyi Chen has over 15 years of experience in the field of Pathology, specializing in Hematopathology. They earned their MD from Peking University Health Science Center and their Ph.D. from Kyoto University and National Cardiovascular Center Research Institute. Dr. Chen is board certified in anatomic and clinical pathology as well as in hematology. Formerly, they held positions at University of California, Davis Medical Center and Loma Linda University Medical Center. Currently, Dr. Chen serves as a Professor of Pathology at UT Southwestern Medical Center and as the Medical Director of the Hematology Lab at Moncrief Cancer Institute.
m*********@******.edu
(214) ***-****
Coppell, Texas
Get a FREE Demo of Dr. Mingyi Chen, MD, PhD's Radar Profile
Review this expert's litigation history, supporting legal docs, publications, professional background, and more.
Comprehensive data on expert witnesses: Access detailed litigation history and performance metrics.
Swift assessment: Quickly evaluate an expert's track record.
Informed decisions: Make better choices when selecting or challenging expert witnesses in any case.
Expert Witness Activity
Plaintiff Cases
Defense Cases
Expert Challenges
Deposition Transcripts
Publications
133
Media & News
167
Social Media Mentions
Expert Institute operates independently and objectively as an expert witness data provider. Expert Institute does not employ, endorse, or have an affiliation with any expert witnesses for which data is provided.
Case Name | Role | Filed Date |
---|
Defense
Plaintiff
0
25
50
75
100
2000
0
2002
0
2004
0
2006
0
2008
0
2010
0
0
25
50
75
100
Radar found 133 records
Title | Type |
---|---|
Cell Segmentation With Globally Optimized Boundaries (CSGO): A Deep Learning Pipeline for Whole-Cell Segmentation in Hematoxylin-and-Eosin–Stained Tissues | Journal Article |
Severely polarized extracellular acidity around tumour cells | Journal Article |
Clinicopathologic features of relapsed CD19(−) B-ALL in CD19-targeted immunotherapy: Biological insights into relapse and LILRB1 as a novel B-cell marker for CD19(−) B lymphoblasts | Journal Article |
Radar monitors a wide array of publication sources, including links to abstracts.
Review book chapters, journal articles, research papers, trade publications, technical reports, conference proceedings, and more.
Radar found 167 records
Title | Description |
---|---|
Program for MobiCom 2024 | Nov 22, 2024 ----- Ke Li, Ruidong Zhang, Boao Chen, Siyuan Chen (Cornell University) ... Mingyi Chen , Ardalan Amiri Sani (University of California, Irvine) ... |
CSGO - Laboratory Investigation | Oct 5, 2024 ----- ... Mingyi Chen , Donghan M. Yang, Yujin Hoshida, Yang Xie, Guanghua Xiao ... 2024 United States & Canadian Academy of Pathology . |
National Merit Scholarship Corporation Recognizes 89 ... | Sep 27, 2024 ----- ... Mingyi Chen . Theodore Chun. Lanzehn Cui. Arihant Deva. Jacey Ding. Emily ... MOST READ. 1. most popular article image. Education Millburn High ... |
Radar scours thousands of media and news sources across the internet 24/7.
Access interviews, webinars, TV appearances, blog posts, columns, whitepapers, PDFs, profressional profiles, and more.
Institution | Degree Type |
---|---|
— | Doctor of Medicine |
Kyoto University | Doctor of Philosophy |
Title | Employer |
---|---|
— | UCLA Santa Monica Medical Center (Los Angeles, CA) |
Professor | UT Southwestern Medical Center (Dallas, TX) |
Associate Medical Director | Shriners Healthcare for Children |
Access detailed litigation history and performance metrics.
Access your Radar profile through Expert iQ, our secure, cloud-based platform that hosts AI-driven insights.
Delivered in 5–7 business days
Receive your profile swiftly, with Radar gathering intelligence from thousands of data points.
24/7 monitoring for 12 months
Stay informed with continuous monitoring and live alerts, ensuring your profile is always up-to-date.